re-read my post D-dawg. It’s a pro PAR post. Gans doing Gans things. I’m clearing up some misunderstanding about the lack of 2mg in stage1 of phase 3 from my own thoughts and understanding. Donna is all over this. No doubt.
Denial, how do you view our funding issues?
Ann: PAR to present at NWR Healthcare Conference, page-28
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.005(2.08%) |
Mkt cap ! $85.73M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.0¢ | 23.0¢ | $180.4K | 746.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 79748 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 22818 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |